The Report
Verified funding, headquarters, and leadership news from the world's most innovative businesses
9,352 reports and counting
evolv Consulting Appoints Matt Gennone Chief Executive Officer
evolv Consulting said former Fractal executive Matt Gennone joined as CEO, with founder Eric Neef moving to Executive Chairman, to lead the firm’s strategy and growth.
v4c Appoints Michael Gibson Chief Executive Officer
v4c promoted Chief Revenue Officer Michael Gibson to Chief Executive Officer to lead the Databricks services partner’s global strategy and execution.
SpyGlass Pharma Opens New Headquarters in Irvine
SpyGlass Pharma opened a 33,000-square-foot headquarters in Irvine, California, on August 27, 2026, moving from its former facility in Aliso Viejo as it prepares for its first product launch.
Providence Medical Technology Appoints Lane Major President and CEO
Providence Medical Technology’s board appointed former Zavation CEO Lane Major as President and CEO, and Major also joins the company’s board of directors.
Cracker Barrel Appoints David Deno Chief Executive Officer
Cracker Barrel appointed former Bloomin’ Brands CEO David Deno as its next CEO, effective August 10, 2026, succeeding Julie Masino.
Cogent Biosciences Raises $475.3 million in Public Offering
Cogent Biosciences, a Biotechnology company based in Waltham MA, has raised $475.3 million in Public Offering at a Undisclosed led by Public market investors.
uniQure Raises $345M in Public Offering
uniQure, a HealthTech company based in Amsterdam, Netherlands, has raised $345M in Public Offering led by Public Markets.
Dianthus Therapeutics Raises $288M in Public Offering
Dianthus Therapeutics, a HealthTech company based in Waltham, MA, has raised $288M in Public Offering led by Public Markets.
Mineralys Therapeutics Raises $287.5M in Public Offering
Mineralys Therapeutics, a HealthTech company based in San Francisco, CA, has raised $287.5M in Public Offering led by Public Markets.
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.